The Interaction of Alcohol Use and Cannabis Use Problems in Relation to Opioid Misuse Among Adults with Chronic Pain

  • Andrew H. Rogers
  • Justin M. Shepherd
  • Daniel J. Paulus
  • Michael F. Orr
  • Joseph W. Ditre
  • Jafar Bakhshaie
  • Michael J. ZvolenskyEmail author
Brief Report



The opioid epidemic is a significant public health crisis and prescription opioids are often used to manage chronic pain, despite questionable long-term efficacy. Furthermore, co-substance (mis)use is also common among individuals with chronic pain who use opioids. Alcohol has been consistently used to manage chronic pain, partly due to its acute analgesic properties. Cannabis has also recently garnered attention in the context of pain management, though research examining its efficacy for pain has produced mixed results. Nevertheless, there is accumulating evidence that concurrent substance co-use is positively associated with use and misuse of additional substances, particularly among individuals with chronic pain. Thus, the goal of this study was to examine the main and interactive effects of alcohol use problems and cannabis use problems in relation to opioid misuse among adults with chronic pain who use opioids.


The current sample was comprised of 440 adults with chronic pain using prescription opioids. Substance use problems were assessed using the ASSIST, Current Opioid Misuse Measure, and the Severity of Dependence Scale. Moderated regressions using the PROCESS macro were utilized.


Results indicated that alcohol use problems and cannabis use problems each uniquely related to opioid dependence severity and opioid misuse. The interaction of alcohol and cannabis use problems was uniquely related to only opioid misuse, whereby alcohol use was most strongly associated to opioid misuse among those with higher levels of cannabis use problems.


Collectively, these findings suggest there may be utility in assessing and treating alcohol and cannabis use problems among persons with chronic pain who are using opioids for pain management.


Funding Information

The current study was funded by the State of Texas funding.

Compliance with Ethical Standards

The study protocol was approved by the Institutional Review Board at the University of Houston and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain Off J Am Pain Soc. 2015;16:769–80.CrossRefGoogle Scholar
  2. 2.
    Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145–61.Google Scholar
  3. 3.
    Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154:2287–96.CrossRefGoogle Scholar
  4. 4.
    Kinnard EN, Philbin MM, Beletsky L. Government actions to curb the opioid epidemic. JAMA. 2018;319:1619–20.CrossRefGoogle Scholar
  5. 5.
    Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–76.CrossRefGoogle Scholar
  6. 6.
    Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician. 2006;9:215–25.Google Scholar
  7. 7.
    Brennan PL, Schutte KK, Moos RH. Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction. 2005;100:777–86.CrossRefGoogle Scholar
  8. 8.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  9. 9.
    Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, et al. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012;13:266–75.CrossRefGoogle Scholar
  10. 10.
    Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119:95–103.CrossRefGoogle Scholar
  11. 11.
    Cleland CM, Rosenblum A, Fong C, Maxwell C. Age differences in heroin and prescription opioid abuse among enrollees into opioid treatment programs. Subst Abuse Treat Prev Policy. 2011;6:11.CrossRefGoogle Scholar
  12. 12.
    Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research [Internet]. Washington (DC): National Academies Press (US); 2011 [cited 2019 Jan 17]. Available from:
  13. 13.
    Von Korff M, Crane P, Lane M, Miglioretti DL, Simon G, Saunders K, et al. Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain. 2005;113:331–9.CrossRefGoogle Scholar
  14. 14.
    Zale EL, Maisto SA, Ditre JW. Interrelations between pain and alcohol: an integrative review. Clin Psychol Rev. 2015;37:57–71.CrossRefGoogle Scholar
  15. 15.
    Moskal D, Maisto SA, De Vita M, Ditre JW. Effects of experimental pain induction on alcohol urge, intention to consume alcohol, and alcohol demand. Exp Clin Psychopharmacol. 2018;26:65–76.CrossRefGoogle Scholar
  16. 16.
    Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012;73:348–62.CrossRefGoogle Scholar
  17. 17.
    Thompson T, Oram C, Correll CU, Tsermentseli S, Stubbs B. Analgesic effects of alcohol: a systematic review and meta-analysis of controlled experimental studies in healthy participants. J Pain Off J Am Pain Soc. 2017;18:499–510.CrossRefGoogle Scholar
  18. 18.
    Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30:300–5.CrossRefGoogle Scholar
  19. 19.
    Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA. 2015;313:2474–83.CrossRefGoogle Scholar
  20. 20.
    Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017;2:96–104.CrossRefGoogle Scholar
  21. 21.
    Martín-Sánchez E, Furukawa TA, Taylor J, Martin JLR. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Med. 2009;10:1353–68.CrossRefGoogle Scholar
  22. 22.
    Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain. 2003;102:211–6.CrossRefGoogle Scholar
  23. 23.
    Rogers AH, Bakhshaie J, Buckner JD, Orr MF, Paulus DJ, Ditre JW, et al. Opioid and cannabis co-use among adults with chronic pain: relations to substance misuse, mental health, and pain experience. J Addict Med [Internet]. 2018 [cited 2019 Jan 2];Publish Ahead of Print. Available from:
  24. 24.
    Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174:1668–73.CrossRefGoogle Scholar
  25. 25.
    Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17:739–44.CrossRefGoogle Scholar
  26. 26.
    Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. J Adolesc Health. 2013;52:158–63.CrossRefGoogle Scholar
  27. 27.
    Clark JMR, Cao Y, Krause JS. Risk of pain medication misuse after spinal cord injury: the role of substance use, personality, and depression. J Pain. 2017;18:166–77.CrossRefGoogle Scholar
  28. 28.
    Kolakowsky-Hayner SA, Gourley EV, Kreutzer JS, Marwitz JH, Cifu DX, Mckinley WO. Pre-injury substance abuse among persons with brain injury and persons with spinal cord injury. Brain Inj. 1999;13:571–81.CrossRefGoogle Scholar
  29. 29.
    Subramaniam GA, Stitzer MA. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Drug Alcohol Depend. 2009;101:13–9.CrossRefGoogle Scholar
  30. 30.
    Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130:144–56.CrossRefGoogle Scholar
  31. 31.
    Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607–14.CrossRefGoogle Scholar
  32. 32.
    Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133–49.CrossRefGoogle Scholar
  33. 33.
    WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addict Abingdon Engl. 2002;97:1183–94.CrossRefGoogle Scholar
  34. 34.
    Zvolensky MJ, Bakhshaie J, Shepherd JM, Peraza N, Garey L, Viana AG, et al. Anxiety sensitivity and smoking among Spanish-speaking Latinx smokers. Addict Behav. 2019;90:55–61.CrossRefGoogle Scholar
  35. 35.
    Hayes AF, Preacher KJ. Conditional process modeling using structural equation modeling to examine contingent causal processes. In: Struct Equ Model Second Course. 2nd ed. Charlotte: Information Age Publishing; 2013. p. 219–66.Google Scholar
  36. 36.
    Serdarevic M, Striley CW, Cottler LB. Gender differences in prescription opioid use. Curr Opin Psychiatry. 2017;30:238–46.CrossRefGoogle Scholar
  37. 37.
    Rogers AH, Kauffman BY, Bakhshaie J, McHugh RK, Ditre JW, Zvolensky MJ. Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain. Am J Drug Alcohol Abuse. in press.Google Scholar
  38. 38.
    Rajabi A, Dehghani M, Shojaei A, Farjam M, Motevalian SA. Association between tobacco smoking and opioid use: a meta-analysis. Addict Behav. 2019;92:225–35.CrossRefGoogle Scholar
  39. 39.
    Witkiewitz K, Vowles KE. Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review. Alcohol Clin Exp Res. 2018;42:478–88.CrossRefGoogle Scholar
  40. 40.
    Hofmann DA, Gavin MB. Centering decisions in hierarchical linear models: implications for research in organizations. J Manag. 1998;24:623–41.Google Scholar
  41. 41.
    Holmbeck GN. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. J Pediatr Psychol. 2002;27:87–96.CrossRefGoogle Scholar
  42. 42.
    Iraurgi Castillo I, González Saiz F, Lozano Rojas O, Landabaso Vázquez MA, Jiménez Lerma JM. Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis. Actas Esp Psiquiatr. 2010;38:270–7.Google Scholar
  43. 43.
    Krantz JH, Dalal R. Chapter 2 - Validity of web-based psychological research. In: Birnbaum MH, editor. Psychol Exp Internet [Internet]. San Diego: Academic Press; 2000. [cited 2019 Jul 8]. p. 35–60. Available from: Scholar

Copyright information

© International Society of Behavioral Medicine 2019

Authors and Affiliations

  1. 1.Department of PsychologyUniversity of HoustonHoustonUSA
  2. 2.Department of PsychologySyracuse UniversitySyracuseUSA
  3. 3.Department of Behavioral ScienceThe University of Texas MD Anderson Cancer CenterHoustonUSA
  4. 4.HEALTH InstituteUniversity of HoustonHoustonUSA

Personalised recommendations